// App-Quantinova.ai

: Parenchymal Crosstalk Regulates Lung Fibrosis Through Bmpr2 and Ctgf Signaling

Researchers

Presenter

  • T. Yanagihara

Principal Investigators

  • S. Sato

  • C. Upagupta

  • K. Ask

  • J. Gauldie

  • M. Kolb

Medical Centers

  • Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada,

  • Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences Tokushima University, Tokushima, Japan,

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Angiology

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Vasodilation dysfunction

  • Pulmonary arterial hypertension

  • Pulmonary fibrosis

  • Hypertension

  • Calcified vascular disease

Biomarkers

  • N/A

Drug/Treatment

  • Tacrolimus

  • Bleomycin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A